January 22, 2019
Prospective Studies Team Partnered with Lundbeck on Accepted Manuscript in Movement Disorders: Clinical Practice
Xcenda's expertise in prospective studies highlighted in high-profile publication, Movement Disorders Clinical Practice. This study was developed in partnership with Lundbeck and examined the real‐world experience of patients taking droxidopa after 6 months of treatment.
ACCEPTED PROSPECTIVE STUDIES MANUSCRIPT
6‐Month Use of Droxidopa for Neurogenic Orthostatic Hypotension
ADD DEPTH TO PRODUCT VALUE PROPOSITION POST-LAUNCH
Prospective Studies
Turn to our team of experts to design and conduct in-depth studies to collect a variety of endpoints. Leverage our full-service support, including protocol development, site selection, and management. IRB submissions and approvals, development and maintenance of EDC tools, patient recruitment statistical analysis, and preparation of final study reports.